লোডিং...
Ocular surface disorders associated with the use of dupilumab based on WHO VigiBase
Dupilumab is a dual inhibitor of interleukin-4 and interleukin-13 and is mainly used to treat moderate-to-severe atopic dermatitis. Post-marketing safety data related to dupilumab have been accumulated, and it has been found that ocular surface diseases are closely associated with dupilumab treatmen...
সংরক্ষণ করুন:
| প্রকাশিত: | Sci Rep |
|---|---|
| প্রধান লেখক: | , , , , , , |
| বিন্যাস: | Artigo |
| ভাষা: | Inglês |
| প্রকাশিত: |
Nature Publishing Group UK
2021
|
| বিষয়গুলি: | |
| অনলাইন ব্যবহার করুন: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8275737/ https://ncbi.nlm.nih.gov/pubmed/34253801 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-021-93750-3 |
| ট্যাগগুলো: |
ট্যাগ যুক্ত করুন
কোনো ট্যাগ নেই, প্রথমজন হিসাবে ট্যাগ করুন!
|